Identification of optimal conditions for the detection of benzo[a]pyrene-DNA adducts by enzyme-linked immunoadsorbent assays (ELISA)

Anticancer Research

Volumn 18, Issue 4 A, 1998, Pages 2669-2674

  Bucci, F ^a   Galati, R ^a   Zito, R ^a   Falasca, G ^a   Federico, A ^a   Verdina, A ^a  

^a REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Benzo a pyrene; Carcinogenesis; DNA adducts; ELISA

Indexed keywords

BENZO[A]PYRENE; POLYCYCLIC AROMATIC HYDROCARBON;

ANIMAL EXPERIMENT; ARTICLE; DNA ADDUCT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

7,8-DIHYDRO-7,8-DIHYDROXYBENZO(A)PYRENE 9,10-OXIDE; ANIMALS; BENZO(A)PYRENE; CARCINOGENS, ENVIRONMENTAL; CATTLE; DNA ADDUCTS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; LIVER; LUNG; MICE; REPRODUCIBILITY OF RESULTS; SPECTROPHOTOMETRY, ULTRAVIOLET;

EID: 0031840281     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. International Agency for Research on Cancer. Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans (World Health Organization, Lyon, France) 32: 211-224, 1983.
2. Gelboin HV: Benzo[a]pyrene metabolism, activation and carcinogenesis: role and regulation of mixed-function oxidases and related enzymes. Physiol Rev 60: 1107-1166, 1980.
3. Weinstein B, Jeffrey AM, Jennette KW, Blobstein SH, Harvey RG, Harris C, Autrup H, Kasai H and Nakanishi K: Benzo[a]pyrene Diol Epoxides as intermediates in nucleic acid binding in vitro and in vivo. Science 193: 592-595, 1976.
4. Miller EC: Some current perspectives on chemical carcinogenesis in humans and experimental animals. Cancer Res 38: 1479-1496, 1978.
5. Phillips DH: Modern methods of DNA adduct determination. C.S. Cooper and P. L. Grover, Handbook of Experimental Pharmacology, 94/I, 503-546. Berlin: Springer-Verlag, 1990.
6. Poirier MC and Weston A: DNA adduct determination in human. Prog Clin Biol Res 374: 205-218, 1991.
7. Gupta RC: Enhanced sensitivity of 32P-postlabeling analysis of aromatic carcinogen: DNA adducts. Cancer Res 45: 5656-5662, 1985.
8. 32P-postlabeling test for structurally diverse DNA adducts. Carcinogenesis 7: 1543-1551, 1986.
9. 32P-postlabelling analysis of DNA adducts formed by food-derived heterocyclic amines: evidence for incomplete hydrolysis and a procedure for adduct pattern simplification. Carcinogenesis 15: 877-882, 1994.
10. Poirier MC: Antibodies to carcinogen-DNA adduct. J Natl Cancer Inst 67: 515-519, 1981.
11. Muller R and Rajewsky MF: Antibodies specific for DNA components structurally modified by chemical carcinogens. J Cancer Res Clin Oncol 102: 99-113, 1981.
12. Peltonen K, Canella K and Dipple A: High-performance liquid Chromatographic separation of purine deoxyribonucleoside monophosphate benzo[a] pyrene adducts. J Chromatography 623: 247-254, 1992.
13. 32P-HPLC suitable for characterization of DNA adducts formed in vitro by polycyclic aromatic hydrocarbons and derivatives. Carcinogenesis 16: 1-9, 1995.
14. Vahakangas K, Haugen A and Harris CC: An applied synchronous fluoresence spectrophotometric assay to study benzo[a]pirene-diolepoxide-DNA adducts. Carcinogenesis(Lond.), 6: 1109-1115, 1985.
15. Weston A, Manchester DK Poirier MC, Choi JS, Trivers GE, Mann DL and Harris CC: Derivative fluorescence spectral analysis of polycyclic aromatic hydrocarbon-DNA adducts in human placenta. Chem Res Toxicol 2: 104-108, 1989.
16. 32P-postlabelling test for covalent DNA binding of chemicals in vivo: application to a variety of aromatic carcinogens and methylating agents. Carcinogenesis 5: 231-243, 1984.
17. Poirier MC: Antisera specific for carcinogen-DNA adducts and carcinogen-modified DNA: application for detection of xenobiotics in biological samples. Mutation Res 288: 31-38, 1993.
18. 32P-postlabelling analysis of nonradioactive aromatic carcinogen-DNA adducts. Carcinogenesis 3: 1081-1092, 1982.
19. Harris CC, Vahakangas K, Newman MJ, Trivers GE, Shamsuddin A, Sinopoli N, Mann DL and Wright WE: Detection of benzo(a)pyrene diol-epoxide-DNA adducts in peripheral blood lymphocytes and antibodies to the adducts in serum from coke oven workers. Proc Natl Acad Sci 82: 6672-6676, 1985.
20. Newman MJ, Ligh BA, Weston A, Tollurud D, Clark JL, Mann DL, Blackmon JP and Harris CC: Detection and characterization of human serum antibodies to polycyclic aromatic hydrocarbon diol-epoxide DNA adducts. J Clin Invest 82: 145-153, 1988.
21. Haugen A, Becher G, Benestad C, Vahakangas K, Trivers GE, Newman MJ, and Harris CC: Determination of polycyclic aromatic in the urine, benzo[a]pyrene-diol-epoxide-DNA adduct in lymphocytes DNA, and antibodies to the adducts in sera from coke oven workers exposed to measured amounts of polydyclic aromatic hydrocarbons in the work atmosphere. Cancer Res 46: 4178-4183, 1986.
22. Veukatachalam S, Denissenko M and Wani AA: DNA repair in human cells: quantitative assessment of bulky anti-BPDE-DNA adducts by non-competitive immunoassay. Carcinogenesis 16: 2029-2036, 1995.
23. Sela M, and Arnon R: Studies on the chemical basis of the antigenicity of proteins. 1. Antigenicity of polypeptidylgelatins. Biochem J 75: 91-102, 1960.
24. Schoket B, Doty WA, Vincze I, Strickland PT, Ferri GM, Assennato G and Poirier MC: Increased sensitivity for determination of polycyclic aromatic hydrocarbon-DNA adducts in human DNA samples by dissociation-enhanced Lanthanide Fluoroimmunoassay (DELFIA). Cancer Epidemiology, Biomarkers & Prevention 2: 349-353, 1993.
25. Santella MR, Dharmaraja N, Gasparro FP and Edelson RL: Monoclonal antibodies to DNA modified by 8-methoxypsoralen and ultraviolet A light. Nucleic Acids Res 13: 2533-2544, 1985.
26. Green N, Alexander H, Olson A, Alexander R, Shinnick TM, Suteliff JG and Lerner RA: Immunogenic structure of the influenza virus emagglutinin. Cell 28: 477-478, 1978.
27. Citro G, Verdina A, Galati R, Floris G, Sabatini S and Finazi-Agro A: Production of the antibodies against the coenzyme pyrrole-quinoline quinone. FEBS Leff 247: 210-214, 1989.
28. Ibanez V, Geantintov NE, Gagliano AG, Brandimarte S and Harvey RG: Physical binding of Tetraols derived from 7,8-Dihydroxy-9,10-epoxybenzo[a]pyrene to DNA. J Am Chem Soc 102: 5661-5666, 1980.
29. Ross JA, Nelson GB, Wilson KH, Rabinowitz JR, Galati A, Stoner GD, Nesnow S and Mass MJ: Adenomas induced by polycyclic aromatic hydrocarbons in strain A/J mouse lung correlate with time-integrated DNA adduct levels. Cancer Res 55: 1039-1044, 1995.
30. Perera FP, Hemminiki K, Young TL, Brenner D, Kelly G and Santella RM: Detection of polycyclic aromatic hydrocarbon-DNA adducts in white blood cells of foudry workers. Cancer Res 48: 2288-2291, 1988.
31. Everson RB, Randerath E, Santella RM, Avits TA, Weinstein IB and Randerath K: Quantitative associations between DNA damage in human placenta and maternal smoking and birth weight. J Natl Cancer Inst 80: 567-576, 1988.
32. Boles TC and Hogan ME: High-resolution mapping of carcinogen binding sites on DNA. Biochemistry 25: 3039-3043, 1986.
33. van Schooten FJ, Kriek E, Steenwinkel MST, Noteborn HPJM, Hillebrand MJX and Leeuwen FEV: The binding efficiency of polyclonal and monoclonal antibodies to DNA modified with benzo[a]pirene diol-epoxide is dependent on the level of modification. Implications for quantitation of benzo[a]pirene-DNA adducts in vivo. Carcinogenesis 8: 1263-1269, 1987.
34. 32P-postlabelling assay for polycyclic aromatic hydrocarbon-DNA adducts. Mutagenesis 8: 121-126, 1993.